Prosecution Insights
Last updated: October 27, 2026

Jacqueline Woznicki, USPTO Patent Examiner

Listed by the USPTO as WOZNICKI, JACQUELINE

Tech Center 3700 • Art Units: 3774

This examiner grants 50% of resolved cases

Analysis

WOZNICKI, JACQUELINE is assigned to Tech Center 3700 and Art Unit 3774. The profile includes 962 resolved cases, a 49.8% allowance rate, a 26.2% interview lift, and a median of 1314 days to allowance. The outcome figure is near an even split in the recorded matters, while the positive interview measure supports using examiner discussions to clarify claim scope and identify viable prosecution paths. The median pendency also favors deliberate docket planning.

The leading companies are Edwards Lifesciences Corporation, Revalve Solutions Inc., and Merit Medical Systems Inc. The leading firms are Knobbe, Martens, Olson & Bear, LLP, Perkins Coie LLP - ReValve Solutions, and FOLEY HOAG, LLP (General). The profile is concentrated in medical devices. Practitioners should prepare interviews around anatomy, operation, and objective claim distinctions, then capture the agreed issues in writing.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

49.8%
Allow Rate
-20.2% vs TC avg
1,080
Total Applications
+26.2%
Interview Lift
1314
Avg Prosecution Days
Based on 962 resolved cases, 2023–2026

Rejection Statute Breakdown

2.0%
§101 Eligibility
16.2%
§102 Novelty
47.7%
§103 Obviousness
32.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17573364 VACUUM SUPENSION SYSTEM WITH HEEL PUMP FOR A PROSTHETIC LEG. Final Rejection Ossur Iceland ehf
18840820 SYSTEMS AND METHODS FOR CONTROLLING A PROSTHETIC BASED ON AMPLIFIED NERVE SIGNALS Non-Final OA The Regents of the University of Michigan
18853494 MULTI-ATLAS ALIGNMENT AND SIZING OF ORTHOPEDIC IMPLANTS Non-Final OA Howmedica Osteonics Corp.
18893096 Humeral Reconstruction System and Methods of Use Non-Final OA Howmedica Osteonics Corp.
17862664 APPARATUS FOR COMPRESSING A REPLACEMENT HEART VALVE IMPLANT Final Rejection BOSTON SCIENTIFIC SCIMED, INC.
18237182 SURGICAL SYSTEM WITH WORKFLOW MONITORING Non-Final OA MAKO Surgical Corp.
18527057 Method and System of Digital Design and Fabrication of a Biomechanical Interface Final Rejection Massachusetts Institute of Technology
18286669 FENESTRATED STENT GRAFT DEVICES AND METHODS OF DEPLOYING FENESTRATED STENT GRAFT DEVICES Final Rejection Mayo Foundation for Medical Education and Research
18288252 ESOPHAGEAL SLEEVE DEVICES AND METHODS OF MAKING THE SAME Non-Final OA The Johns Hopkins University
18315561 SACROILIAC JOINT FUSION IMPLANTS Final Rejection GLOBUS MEDICAL, INC.
18008723 A PROSTHETIC HEART VALVE WITH IMPROVED SEALING MEANS Non-Final OA BIOTRONIK AG
17799832 Heart valve prosthesis Final Rejection BIOTRONIK AG
18308239 GROWTH-ACCOMMODATING VALVE SYSTEM Final Rejection THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
17470324 KNEE JOINT ENDOPROSTHESIS APPARATUS AND KNEE JOINT ENDOPROSTHESIS Non-Final OA Aesculap AG
18652967 COMMISSURE MARKER FOR A PROSTHETIC HEART VALVE Final Rejection EDWARDS LIFESCIENCES CORPORATION
18590740 SYSTEMS AND METHODS TO OCCLUDE A VALVULAR COMMISSURE OR CLEFT Final Rejection EDWARDS LIFESCIENCES CORPORATION
18096728 DEVICES AND METHODS FOR ADJUSTING THE TENSIONS OF LEAFLETS MOUNTED WITHIN PROSTHETIC VALVES Final Rejection Edwards Lifesciences Corporation
18015707 MECHANICALLY EXPANDABLE PROSTHETIC DEVICE Final Rejection Edwards Lifesciences Corporation
18075939 CAPSULE FOR A DELIVERY APPARATUS FOR A PROSTHETIC MEDICAL DEVICE Non-Final OA Edwards Lifesciences Corporation
17798627 PROSTHETIC KNEE JOINT WITH ELECTRONICALLY-CONTROLLED TRANSMISSION Non-Final OA Vanderbilt University
17797320 METHOD FOR DETECTING INTENT IN AN ADAPTIVE LOWER LIMB DEVICE Non-Final OA Vanderbilt University
18030957 AUTOMATIC PATELLAR TRACKING IN TOTAL KNEE ARTHROPLASTY Final Rejection Smith & Nephew Orthopaedics AG
18808235 DEVICES AND METHODS FOR MULTI-ALIGNMENT OF IMPLANTABLE MEDICAL DEVICES Non-Final OA Medtronic, Inc.
18323132 KNEE JOINT Final Rejection The University of Tokyo
17473559 Atrioventricular Valve Repair Ring Non-Final OA The Medical College of Wisconsin, Inc.
18078471 SUB-RETINAL PROSTHESIS USING MULTI-PHOTODIODE SENSING TECHNOLOGY Non-Final OA KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
17683202 INTRAOCULAR LENS COMPRISING AN ARM WITH AN ADJUSTABLE LENGTH AS A HAPTIC Non-Final OA Carl Zeiss Meditec AG
18002219 MINIMAL FRAME PROSTHETIC CARDIAC VALVE DELIVERY DEVICES, SYSTEMS, AND METHODS Final Rejection SHIFAMED HOLDINGS, LLC
18842727 POLYMERIC HEART VALVE SYSTEM AND METHODS OF MAKING AND USING THEREOF Non-Final OA The Research Foundation for The State University of New York
18469651 BRANCHABLE STENT GRAFT Final Rejection Medtronic Vascular, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Jacqueline Woznicki's allowance rate?

49.8% of resolved applications examined by Jacqueline Woznicki were allowed (962 resolved cases), compared with 61.7% across Art Unit 3774 over the last five years.

Does an interview help with examiner Jacqueline Woznicki?

This examiner's interview lift is +26.2 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Jacqueline Woznicki take to allow a patent?

Applications allowed by Jacqueline Woznicki took 1,314 days on average from filing to allowance.

Which art unit does examiner Jacqueline Woznicki work in?

Jacqueline Woznicki examines applications in Art Unit 3774 in Tech Center 3700 (Medical Devices & Mechanical Engineering).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month